Substituted S-alaninate derivatives

US11912692B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Hartmut Beck · Wuppertal, DE
• Stefanie Katharina MESCH · Wuppertal, DE
• Alexandros Vakalopoulos · Hilden, DE
• Nils Pfaff · Düsseldorf, DE
• Stefanie Zimmermann · Düsseldorf, DE
• Markus Follmann
• Elisabeth Kersten · Wuppertal, DE
• Guillaume Levilain · Wuppertal, DE
• Kartrin Partikel · Wuppertal, DE
• Andreas Peter Broehl · Wuppertal, DE
• Stefan Heitmeier · Wülfrath, DE
• Julia Dietze-Torres · Wuppertal, DE
• Lutz Lehmann · Berlin, DE
• Kersten Matthias Gericke · Wuppertal, DE
• Frank Süβmeier · Birkenfeld, DE
• Lars Bärfacker · Oberhausen, DE
• Alexander Hillisch · Solingen, DE
• Adrian Tersteegen · Wuppertal, DE
• Anja Buchmüller · Essen, DE
• Christoph Gerdes

Key dates

• Filing date: Aug 11, 2023
• Grant date: Feb 27, 2024
• Expiry date: Aug 11, 2043

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P7/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to substituted S-alaninate derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular vascular disorders, preferably thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complications.